98%
921
2 minutes
20
Purpose This systematic review aims to integrate the medium-term outcomes of four-implant supported overdentures (IODs) and full arch fixed restorations (IFRs) in the maxilla. Materials and Methods The search was performed in PubMed, Embase, and Cochrane databases, complemented by manual search. The inclusion criteria were at least 10 maxillary edentulous patients restored by IOD or IFR and at least five years of follow up. RoB 2, and NOS tools were used to assess risk of bias. Implant survival rate (ISR) was calculated as primary outcome. Protheses survival rate, marginal bone loss (MBL), and complications were the secondary outcomes. Results Sixteen studies with a total of 5568 implants met the criteria (nine on IODs, seven on IFRs). The weighted ISR of IODs was 94.5% (95% CI [92.1%, 96.9%], I2:84.22%), and subgroup analysis was performed on attachment system and study type. The weighted ISR of IFRs was 98.5% (95%CI [97.4%, 99.5%], I2:77.88%). For prostheses survival, the rate of 85.0% in IODs was lower than that of 99.9% in IFRs. MBL in the fifth year was -0.27±1.31 mm in IODs and -1.20±0.76 mm in IFRs. Retention loss (0.34 per patient) and dislodgement/fracture of the acrylic teeth (0.09 per patient) were the most common complications in IODs and IFRs, respectively. Conclusions Despite the variance of baseline, IFRs had a relatively higher implant and protheses survival rate than IODs, whereas IODs had less MBL at the fifth year and higher incidence rate of complications. Both fourimplant- supported maxillary overdentures and full arch fixed restorations have predictable medium-term clinical results.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11607/jomi.11175 | DOI Listing |
World J Surg Oncol
September 2025
Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Background: Inflammation impacts the prognosis of numerous types of tumors. Inflammatory indicators such as the neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-eosinophil ratio (NER) have emerged as potential prognostic markers and are closely correlated with the outcomes of cancer patients. However, the connection between NER and cancer prognosis remains incompletely understood.
View Article and Find Full Text PDFInt J Clin Oncol
September 2025
Department of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Background: Lenvatinib plus pembrolizumab (LP) therapy has emerged as an effective treatment for patients with advanced or recurrent endometrial cancer. However, limited data are available regarding its outcomes in real-world settings. This study aimed to identify prognostic factors associated with the efficacy of LP therapy.
View Article and Find Full Text PDFAdv Med Sci
September 2025
Chair and Department of Medical Microbiology, Medical University of Lublin, Lublin, Poland. Electronic address:
Purpose: The aim of the study was to evaluate the toxicity of triclosan in the Danio rerio model and mammalian cells, as well as to assess its antimicrobial and antibiofilm activity against selected bacterial pathogens.
Methods: Triclosan toxicity was assessed in Danio rerio embryos in accordance with OECD Test Guideline 236: Fish Embryo Acute Toxicity (FET) Test. Cytotoxicity was evaluated in vitro using the MTT assay on human dermal fibroblasts (BJ) and rat cardiomyoblasts (H9c2).
J Gastrointest Surg
September 2025
Department of thoracic surgery, Army Medical Center of PLA, Chongqing, China. Electronic address:
Background: The objective of this study was to evaluate the efficacy, safety, as well as the 3-year survival outcomes of neoadjuvant immunotherapy with chemotherapy (NICT) plus surgery in patients with locally advanced esophageal squamous cell carcinoma (ESCC) in real-world settings.
Methods: We performed a retrospective analysis of patients with locally advanced ESCC who underwent surgery after NICT in our hospital between May 2019 and Mar 2022, with a median follow-up of 37.6 months.
Lab Invest
September 2025
Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA. Electronic address:
Sinonasal mucosal melanoma (SNMM) is a rare aggressive malignancy of the sinonasal tract. Due to its advanced clinical presentation and frequent late-stage diagnosis, the 5-year survival rate is less than 30%, with an even worse prognosis in patients with distant metastasis (SNMM-M). Therefore, characterizing the molecular landscape of SNMM may provide novel therapeutic targets for SNMM-M.
View Article and Find Full Text PDF